Industry News (Patents and Technology)

Patent Allowance Received for Tamoxifen Analogs

Published in Cancer Weekly, February 10th, 1997

Pharmos, Alachua, Florida, announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent with claims covering permanently ionic derivatives of steroid hormones and their antagonists.

Pharmos scientists designed and developed the compounds internally. This patent allowance defines broad therapeutic applications for the use of charged derivatives of steroid hormone analogs and antagonists in the treatment of cancer and inflammation.

The allowed patent is based on preclinical data demonstrating the potential superior therapeutic and side effect profile of these novel pharmaceuticals compared to conventional...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-02-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry